UBC Medical Indonesia Tbk. vs Trias Sentosa Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Trias Sentosa Tbk. trades at Rp484 (market cap 1.36T, 17.9K 24h volume). The key difference: Trias Sentosa Tbk. is far larger — about 2.4× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 17.9K). Which is the better fit depends on your goals.
| LABS | TRST | |
|---|---|---|
Market Cap | 576.7B | 1.36T |
Volume | 3.48M | 17.9K |
Lot | 34.82K | 179 |
Turnover | 522.79M | 8.65M |
Average Price | 150.13 | 483.4 |
Value | 522.79M | 8.65M |
Indicative Equilibrium Price | 148 | 484 |
Indicative Equilibrium Volume | 350 | 150 |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Trias Sentosa Tbk was established on November 23, 1979 and started commercial operation in 1984 with total capacity of 4.500 tons BOPP (biaxially oriented polypropylene) film per annum. In 1989, the Company completed expansion of its second line BOPP film with capacity of 7.500 tons per annum. In 1993, the Company completed its expansion of third line BOPP film with capacity of 12.000 tons per annum, and in 1995, Polyester film project with total capacity of 12.000 tons were completed. In 1996, the Company completed its expansion of fourth line BOPP film with total capacity of 16.000 tons. Currently, the Company is the largest BOPP Film and Polyester Film producer in Indonesia.
Read more on TRST →